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Novel Internationally Verified Method Reports
Desmoplastic Reaction as the Most Significant Prognostic
Feature For Disease-specific Survival in Stage II
Colorectal Cancer
Ines P. Nearchou, BSc,* Yoshiki Kajiwara, MD, PhD,† Satsuki Mochizuki, PhD,†
David J. Harrison, MD,* Peter D. Caie, PhD,* and Hideki Ueno, MD, PhD†
Abstract:Multiple histopathologic features have been reported as
candidates for predicting aggressive stage II colorectal cancer
(CRC). These include tumor budding (TB), poorly differentiated
clusters (PDC), Crohn-like lymphoid reaction and desmoplastic
reaction (DR) categorization. Although their individual prog-
nostic signiﬁcance has been established, their association with
disease-speciﬁc survival (DSS) has not been compared in stage II
CRC. This study aimed to evaluate and compare the prognostic
value of the above features in a Japanese (n= 283) and a Scottish
(n= 163) cohort, as well as to compare 2 different reporting
methodologies: analyzing each feature from across every tissue
slide from the whole tumor and a more efﬁcient methodology
reporting each feature from a single slide containing the deepest
tumor invasion. In the Japanese cohort, there was an excellent
agreement between the multi-slide and single-slide methodologies
for TB, PDC, and DR (κ= 0.798 to 0.898) and a good agreement
when assessing Crohn-like lymphoid reaction (κ= 0.616). TB
(hazard ratio [HR]= 1.773; P= 0.016), PDC (HR= 1.706;
P= 0.028), and DR (HR= 2.982; P< 0.001) based on the single-
slide method were all signiﬁcantly associated with DSS. DR was
the only candidate feature reported to be a signiﬁcant in-
dependent prognostic factor (HR= 2.982; P< 0.001) with both
multi-slide and single-slide methods. The single-slide result was
veriﬁed in the Scottish cohort, where multivariate Cox regression
analysis reported that DR was the only signiﬁcant independent
feature (HR= 1.778; P= 0.002) associated with DSS. DR was
shown to be the most signiﬁcant of all the analyzed histopatho-
logic features to predict disease-speciﬁc death in stage II CRC.
We further show that analyzing the features from a single-slide
containing the tumor’s deepest invasion is an efﬁcient and
quicker method of evaluation.
Key Words: desmoplastic reaction, tumor budding, poorly dif-
ferentiated clusters, prognosis, colorectal cancer
(Am J Surg Pathol 2019;00:000–000)
Colorectal cancer (CRC) is one of the most commoncancers worldwide. To date, the tumor node metastasis
staging is the basis for both prognostic stratiﬁcation and
therapeutic management of CRC patients.1,2 However, a
growing awareness exists that due to the heterogeneity
present within the tumor microenvironment of CRC, addi-
tional prognostic features may prove valuable in subdividing
CRC patients into more accurate prognostic groups and to
improve their therapeutic consequences. This need is par-
ticularly relevant to stage II CRC patients where around
20% of the patients experience poor outcome.3
Over the past decades, extensive research has been
conducted to identify signiﬁcant prognostic features that im-
prove upon tumor node metastasis prediction of stage II CRC
patient outcome. Such include features of the tumor such as
tumor budding (TB)4–8 or poorly differentiated clusters
(PDC)9–14 as well as the host’s interaction with the tumor such
as the lymphocytic15–18 and desmoplastic reaction (DR).19–21
Although previous studies have compared and estab-
lished the prognostic value of TB and PDC in CRC,4–6,8–14
their clinical assessment has not yet been implemented in
practice, mainly due to the nonstandardized methodology
for its assessment; something that the International Tumor
Budding Consensus Conference aimed to address.2
The lymphocytic reaction within the tumor micro-
environment has shown to be a prognostic factor in CRC.
From the *Department of Quantitative and Digital Pathology, School of
Medicine, University of St Andrews, St Andrews, UK; and
†Department of Surgery, National Defense Medical College, Saita-
ma, Japan.
IMMUNOSCORE is a registered trademark owned by INSERM.
Conﬂicts of Interest and Source of Funding: This study was funded by
Medical Research Scotland and the Japan Society for the Promotion
of Science in collaboration with the British Council. The authors have
disclosed that they have no signiﬁcant relationships with, or ﬁnancial
interest in, any commercial companies pertaining to this article.
Correspondence: Ines P. Nearchou, BSc, Department of Quantitative and
Digital Pathology, School of Medicine, University of St Andrews, St
Andrews KY16 9TF, UK (e-mail: i.p.nearchou@gmail.com).
Supplemental Digital Content is available for this article. Direct URL ci-
tations appear in the printed text and are provided in the HTML and
PDF versions of this article on the journal’s website, www.ajsp.com.
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health,
Inc. This is an open-access article distributed under the terms of the
Creative Commons Attribution-Non Commercial-No Derivatives
License 4.0 (CCBY-NC-ND), where it is permissible to download and
share the work provided it is properly cited. The work cannot be
changed in any way or used commercially without permission from
the journal.
ORIGINAL ARTICLE
Am J Surg Pathol  Volume 00, Number 00, ’’ 2019 www.ajsp.com | 1
Previous research has demonstrated its reporting by the
evaluation of nodular lymphoid aggregates referred to as
Crohn-like lymphoid reaction (CLR).17,22–24 Another
factor concerning the host’s reaction to the tumor is des-
moplasia, deﬁned by the presence of ﬁbrosis at the tumor’s
invasive front.19–21,25 Histologic classiﬁcation of the DR in
stage II, III, and IV CRC, has been shown to be an in-
dependent predictor of relapse-free survival and disease-
speciﬁc survival (DSS).21
Unlike studies on TB and PDC, the prognostic value
of CLR and DR has not been extensively veriﬁed, speciﬁ-
cally interinstitutionally and internationally. The published
methodology for evaluating the aforementioned features
include the assessment of each diagnostic slide containing
tumor and the identiﬁcation of all those that include any
tumor invasive front. CLR or DR are reported across each
slide containing any invasive front, and TB or PDC “hot-
spots” are located before their quantiﬁcation. Reporting
each of the above features from the same single tissue sec-
tion containing the deepest portion of the invasive front
would be less labor-intensive and would reduce the time and
effort required for their assessment by the pathologist. In
this study, we ﬁrstly aimed to further verify and compare
these feature’s prognostic signiﬁcance with DSS by applying
the previously published guidelines for their assessment.
Second, we aimed to explore how the reporting of these
features across a single-slide would compare with their
assessment across all slides containing any invasive front.
MATERIALS AND METHODS
Study Design and Patient Cohort
The patient material for this study comprised of an initial
cohort of 283 stage II CRC patients who underwent surgical
resection over the years 2006 to 2011 in the National Defense
Medical College Hospital (NDMCH), Japan. A further inter-
national veriﬁcation cohort of 163 patients treated between the
years 2002 to 2005 from hospitals in Edinburgh, Scotland was
studied. Neither cohort had been previously analyzed for the
candidate prognostic features reported in this study. Associated
clinicopathologic data included features such as pT stage, lo-
cation of the tumor, differentiation, histologic type, and follow-
up information; up to 9.3 years DSS for the Japanese cohort
and up to 11.5 years for the Scottish cohort. Detailed patient
characteristics can be found in Table 1 (Japanese cohort) and
Supplementary Table 1 (Supplemental Digital Content 1,
http://links.lww.com/PAS/A803; Scottish cohort). This study
was approved by the Ethics Committee of the National De-
fense Medical College (approval ref: No.2992) and after review
by the NHS Lothian NRS BioResource, REC-approved Re-
search Tissue Bank (REC approval ref: 13/ES/0126), granted
by East of Scotland Research Ethics Service. All samples had
been anonymized before the commencement of the study.
Histopathologic Evaluation of Candidate
Features
Hematoxylin and eosin (H&E) slides previously pre-
pared for routine clinical reporting were used in this study.
Slides from the NDMCH comprised specimens of longitudinal
cut, whereas the ones from Edinburgh hospitals were of cross-
sectional cut. All tumor slides were initially assessed to identify
those containing any invasive front (multi-slide method). Once
those were found, the features mentioned below were assessed
using glass slides under an objective lens with ×20 magniﬁca-
tion with a 20-mm eyepiece ﬁeld number diameter (Olympus
BX53, Tokyo, Japan) for the Japanese cohort. The median
number of slides examined per patient was 6 (range, 1 to 21).
The slide containing the deepest part of the invasive front of
the tumor was then selected and revaluated (single-slide
method). Findings from the single-slide methodology applied
to the Japanese cohort were then veriﬁed on a single H&E
slide, which contained the tumor’s deepest invasion from the
Scottish cohort. The evaluation of the single-slide from both
the Japanese and Scottish cohorts was performed on digitized
H&E slides. Whole slide H&E images were captured with a
×20 objective using a Leica Aperio AT2 (Leica Microsystems,
Wetzlar, Germany) for the Japanese cohort and an Axioscan.
Z1 (Zeiss, Oberkochen, Germany) for the Scottish cohort.
Features were then assessed using the Aperio ImageScope
pathology slide viewing software (version 12.3.3; Leica Mi-
crosystems), and the ZEN imaging software (version 2.3 blue
edition; Zeiss) for each whole slide scanner’s images re-
spectively.
Tumor Budding
Tumor buds were deﬁned as cancer clusters of up to 4
cells in the invasive front region. TB was initially assessed on
the Japanese cohort according to the recommendations by
the International Tumor Budding Consensus Conference.2
Brieﬂy, from all slides containing the invasive front, the slide
containing the greatest degree of budding was ﬁrstly se-
lected. Tumor buds were counted in the “hotspot” region at
×20 objective (area, 0.785mm2). Tumors with 0 to 4 buds
per 0.785mm2 were classed as grade 1, 5 to 9 buds as
grade 2 and ≥ 10 buds as grade 3 (Fig. 1A). Using the same
categorization system, we reassessed TB on a single tissue
slide containing the deepest part of the tumor on both
the Japanese and Scottish cohorts.
Poorly Differentiated Clusters
Non–gland-forming cancer clusters of ≥ 5 cancer
cells invading into the stroma were deﬁned as PDC.
Similarly to the TB assessment, all tissue slides containing
the tumor front were initially assessed to identify the slide
with the highest number of PDC. Within that slide, the
region at ×20 objective where PDC was most intensively
observed was assessed. Tumors with 0 to 4 PDC were
classed as grade 1, 5 to 9 PDC as grade 2 and ≥ 10 PDC as
grade 3 (Fig. 1B). The same categorization system was
then used when applying the single-slide method.
Crohn-like Lymphoid Reaction
CLR assessment was performed as previously
described.17 Brieﬂy, the presence of nodular lymphoid
aggregates surrounding the tumor periphery of size ≥ 1
mm was classed as CLR (Fig. 1C). Nodular lymphoid
aggregates of smaller size or present within or just below
the mucosa layer were not evaluated as CLR and therefore
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tumors with such features were classed as CLR absent
tumors. CLR was initially assessed across all slides
containing any invasive front in the Japanese cohort.
CLR was then reassessed on a single-slide containing the
tumor’s deepest invasion from both the Japanese and
Scottish cohorts.
Desmoplastic Reaction
DR was classiﬁed as immature, intermediate, or
mature based on the 3-tier categorization system pre-
viously proposed.21 Presence of myxoid stroma greater
than a microscopic ﬁeld of a ×40 objective lens within the
extramural tumor front was regarded as immature
(Fig. 1D). If myxoid stroma (greater than a microscopic
ﬁeld of a ×40 objective lens) was not present but the
extramural tumor front included keloid-like collagens, the
stroma was classiﬁed as intermediate (Fig. 1E). Absence of
size signiﬁcant myxoid stroma and keloid-like collagens
was regarded as mature stroma (Fig. 1F). As per the
evaluation of previous features, all slides containing any
tumor invasive front from the Japanese cohort was
initially assessed for DR before the slide containing only
the deepest part of the tumor of the Japanese and Scottish
cohorts was reassessed.
Statistical Analyses
To assess the agreement between the 2 method-
ologies used to evaluate the histopathologic features, the
weighted κ was calculated.26–28 The weighted κ was also
calculated for assessing the agreement among the ob-
servers (I.P.N. and Y.K.) for the single-slide method of
each feature reported on a randomly selected sample set
(n= 50, 25 from the Scottish cohort and 25 from the
Japanese cohort). Associations among the evaluated fea-
tures and between the features and the data from the
clinicopathologic report were analyzed using the χ2 test.
Univariate Cox regression was performed to assess the risk
of disease-speciﬁc death over time for all histopathologic
TABLE 1. Univariate and Multivariate Cox Regression Analysis For Clinicopathologic Data and Features Assessed on All Slides
Containing the Invasive Front of the Japanese Cohort
Univariate Multivariate
Features
Frequency
(%) HR (95% CI) P HR (95% CI) P
Age 1.772 (0.944-3.325) 0.075 —
≤ 70 177 (62.5)
71-79 85 (30.0)
≥ 80 21 (7.4)
Sex 1.292 (0.560-2.979) 0.548 —
Male 184 (65.0)
Female 99 (35.0)
pT stage 1.523 (0.612-3.794) 0.366 NS
pT3 231 (81.6)
pT4 52 (18.4)
Tumor site 1.612 (0.959-2.709) 0.071 —
Left 76 (26.9)
Right 92 (32.5)
Rectal 115 (40.6)
Differentiation 1.047 (0.699-1.570) 0.822 NS
Moderate 113 (39.9)
Poor 25 (8.8)
Well 145 (51.2)
Tumor type —
Adenocarcinoma 266 (94.0)
Mucinous 17 (6.0)
DR on all slides 2.980 (1.627-5.459) < 0.001 2.980 (1.627-5.459) < 0.001
Mature 90 (31.8)
Intermediate 105 (37.1)
Immature 88 (31.1)
PDC on all slides 1.613 (0.972-2.677) 0.065 NS
G1 84 (29.7)
G2 106 (37.5)
G3 93 (32.9)
TB on all slides 1.749 (1.064-2.877) 0.028 NS
G1 103 (36.4)
G2 84 (29.7)
G3 96 (33.9)
CLR on all slides 0.655 (0.296-1.447) 0.295 NS
Present 146 (51.6)
Absent 137 (48.4)
Signiﬁcant features (P≤ 0.05) are shown in bold.
G1 indicates grade 1; G2, grade 2; G3, grade 3; NS, not signiﬁcant.
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features evaluated. Multivariate Cox regression with a
forward stepwise method was applied in SPSS 24,29 to
select the most signiﬁcant prognostic histopathologic fea-
tures that added value to any ﬁnal model. P-values ≤ 0.05
were regarded as statistically signiﬁcant. Kaplan-Meier
(KM) analysis was used to plot the survival curves of the 4
candidate histopathologic features assessed. Unless oth-
erwise stated, R studio 1.1.419 running R 3.4.330,31 was
used to perform all above analyses.
RESULTS
Patients’ Characteristics
Patients’ characteristics from both Japanese and
Scottish cohorts are shown in Table 1 and Supplementary
Table 1 (Supplemental Digital Content 1, http://links.lww.
com/PAS/A803), respectively. This study included a
Japanese cohort of 283 stage II CRC patients of which 99
were female and 184 male. Within the Scottish cohort
(N= 163), 76 were female and 87 were male patients.
Within the Japanese cohort, 231 patients were of pT3 and
52 of the pT4 stage, whereas there were 110 pT3 and 53
pT4 stage patients in the Scottish cohort. The age of pa-
tients ranged from 31 to 99 years (median 68 y) and from
37 to 96 years (median, 74 y) in the Japanese and Scottish
cohorts respectively.
Method Agreement Analysis
Two separate quantiﬁcation methodologies were as-
sessed for the evaluation of the candidate prognostic fea-
tures; TB, PDC, CLR, and DR. The ﬁrst methodology was
based on the previous recommendations for their reporting,
where all glass tissue slides containing any invasive front are
FIGURE 1. Histopathologic findings of tumor buds, PDC, CLR, and DR on H&E-stained slides. A, TB (cancer clusters of up to 4 cells)
are shown by the black arrows. B, PDC (cancer clusters ≥5 cells) are shown by the black arrows. C, CLR present below the
muscularis mucosa. D, Myxoid stroma defined by the presence of enlarged extracellular matrix and keloid like collagens with
random directionality (immature type DR). E, Keloid-like collagen, that is, thick bands of collagen with bright eosinophilic hyali-
nization (intermediate type DR). F, Mature type DR with fibrotic stroma without myxoid stroma and keloid-like collagen.
Nearchou et al Am J Surg Pathol  Volume 00, Number 00, ’’ 2019
4 | www.ajsp.com Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc.
assessed. The second methodology reports all candidate
features from a single digitized tissue slide containing the
deepest tumor invasion. To assess the agreement between
the 2 methodologies, the weighted κ was calculated. Results
revealed that the 2 methodologies were in excellent agree-
ment for the assessment of TB, PDC, and DR (κ= 0.898,
0.798, and 0.827, respectively). The κ value for the agree-
ment between the 2 methods for the evaluation for CLR was
shown to be good (κ= 0.616) (Supplementary Table 2,
Supplemental Digital Content 1, http://links.lww.com/PAS/
A803).
Interobserver Agreement on Single-slide
Method
Two observers (I.P.N. and Y.K.) scored a subset of 50
patients, 25 from each cohort, for all candidate histopathologic
features. The κ value for the agreement of the assessments was
excellent for TB, PDC, and DR (0.809, 0.801, 0.829, re-
spectively), however, was moderate for CLR (0.448).
Correlations between Features
Features Assessed on Multiple Slides
The relationship between TB, PDC, CLR, and DR
evaluated using the multi-slide method was assessed by the χ2
test. Their relationship with the patient data was also assessed
using the χ2 test. DR was signiﬁcantly associated with ad-
vanced T stage (P=0.003). TB was associated with tumor
type (P=0.038) (Supplementary Table 3, Supplemental
Digital Content 1, http://links.lww.com/PAS/A803). No other
candidate feature was associated with any clinicopathologic
characteristic. The degree of TB was signiﬁcantly associated
with the degree of PDC (P<0.001) and DR (P=0.001).
PDC was also correlated with DR (P<0.001). No associa-
tion was found between CLR and any other candidate fea-
ture (Supplementary Table 4, Supplemental Digital Content
1, http://links.lww.com/PAS/A803).
Features Assessed on a Single-slide
The χ2 test was further applied to analyze the associa-
tions between the candidate features, utilizing the single-slide
methodology, and the data from the clinicopathologic report.
Within the Japanese cohort, there was a statistically sig-
niﬁcant correlation between the PDC, CLR, DR, and pT
stage (P=0.040, 0.011, and 0.002, respectively) (Supple-
mentary Table 5, Supplemental Digital Content 1, http://
links.lww.com/PAS/A803). TB (P<0.001), PDC (P<0.001),
and CLR (P=0.005) were all signiﬁcantly associated with
DR. TB was also signiﬁcantly associated with CLR
(P=0.024) and PDC (P<0.001) (Supplementary Table 6,
Supplemental Digital Content 1, http://links.lww.com/PAS/
A803). Results from the Scottish cohort showed that PDC
and TB were both signiﬁcantly associated with pT stage
(P=0.006 and <0.001, respectively) and differentiation
(P=0.016 and <0.001, respectively) (Supplementary Table 7,
Supplemental Digital Content 1, http://links.lww.com/PAS/
A803). Furthermore, TB was shown to be signiﬁcantly cor-
related with the degree of PDC (P<0.001) as well as DR
(P<0.001). PDC was also shown to be associated with
DR (P=0.010). CLR was not shown to be signiﬁcantly
associated with any other candidate feature in the Scottish
cohort (Supplementary Table 8, Supplemental Digital Con-
tent 1, http://links.lww.com/PAS/A803).
Survival Analysis
Features Assessed on Multiple Slides From the
Japanese Cohort
Univariate Cox regression was performed to assess the
prognostic signiﬁcance of all clinicopathologic data and the
candidate features assessed on all slides containing the in-
vasive front. None of the clinicopathologic data, including
pT stage and differentiation, were reported as signiﬁcant
predictors of DSS. Of the candidate histopathologic features
assessed in this study, TB (hazard ratio [HR]=1.749; 95%
conﬁdence interval [CI], 1.064-2.877; P= 0.028) and DR
(HR= 2.980; 95% CI, 1.627-5.459; P< 0.001) were sig-
niﬁcantly associated with DSS, whereas PDC only trended
to signiﬁcance. CLR was not reported as signiﬁcant in this
study (Table 1). KM survival analysis was calculated for the
4 candidate features; TB, PDC, CLR, and DR (Fig. 2).
Results showed that in regard to TB, the 9.3-year DSS was
87.4% for grade 1, 69.4% for grade 2, and 63.9% for grade 3.
This trend was similarly observed when assessing the DSS
rate for PDC; 88.1% for grade 1, 77.0% for grade 2, and
60.3% for grade 3. No discernable difference was observed
in the survival rates according to CLR (73.3% survival for
negative and 72.8% survival for positive). The 9.3-year DSS
for the DR categorization was reported as 97.5% for the
mature group, 74.8% for the intermediate group, and only
50.3% in the immature. DR (P= 0.0003) was the only
candidate feature to signiﬁcantly stratify the patients within
this cohort by KM analysis. When assessing which features
added value to the prediction of disease-speciﬁc death,
forward stepwise multivariate Cox regression was applied
and the predictive model was adjusted for TB, PDC, CLR,
DR, and the gold standards of pT stage and differentiation.
Results showed only DR (HR= 2.980; 95% CI, 1.627-5.459;
P< 0.001) to be an independent signiﬁcant survival
predictor (Table 1).
Features Assessed on a Single-slide of the Japanese
Cohort
Following the reassessment of all candidate features
reported from the same single-slide that contained the
deepest invasion of the tumor, univariate Cox regression
was applied to assess their prognostic signiﬁcance (Table 2).
The results revealed that TB (HR= 1.773; 95% CI, 1.111-
2.829; P= 0.016), PDC (HR= 1.706; 95% CI, 1.061-2.745;
P= 0.028) and DR (HR= 2.982; 95% CI, 1.702-5.223;
P< 0.001) were all signiﬁcantly associated with a risk of
disease-speciﬁc death. CLR was again not shown to have a
prognostic signiﬁcance. When KM survival curves were
plotted, the results reﬂected those of the multi-slide
methodology, where patients were stratiﬁed based on the
reporting of the candidate features, albeit only signiﬁcantly
for TB (P= 0.047) and DR (P< 0.0001) (Fig. 2).
Multivariate forward stepwise Cox regression analysis
adjusted for TB, PDC, CLR, and DR, resulted in DR to
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FIGURE 2. KM survival analysis for TB grade, PDC grade, CLR, and categorization of DR for the Japanese cohort (using all slides containing
any invasive front and a single-slide containing the deepest tumor invasion) and for the Scottish cohort (single-slide). A, TB evaluated on all
tissue slides containing any invasive front from the Japanese cohort. B, TB assessed on a single tissue slide containing the deepest tumor
invasion from the Japanese cohort. C, TB assessed on a single tissue slide containing the deepest tumor invasion from the Scottish cohort. D,
PDC evaluated on all tissue slides containing any invasive front from the Japanese cohort. E, PDC assessed on a single tissue slide containing
the deepest tumor invasion from the Japanese cohort. F, PDC assessed on a single tissue slide containing the deepest tumor invasion from the
Scottish cohort. G, CLR evaluated on all tissue slides containing any invasive front from the Japanese cohort. H, CLR assessed on a single tissue
slide containing the deepest tumor invasion from the Japanese cohort. I, CLR assessed on a single tissue slide containing the deepest tumor
invasion from the Scottish cohort. J, DR evaluated on all tissue slides containing any invasive front from the Japanese cohort. K, DR assessed on
a single tissue slide containing the deepest tumor invasion from the Japanese cohort. L, DR assessed on a single tissue slide containing the
deepest tumor invasion from the Scottish cohort. P values from KM analysis. HR and CI from univariate Cox regression analysis.
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be the only signiﬁcant predictor of survival (HR= 2.982;
95% CI, 1.702-5.223; P< 0.001) (Table 2).
Single-slide Method Veriﬁed on Scottish Cohort
The faster and more efﬁcient single-slide methodology
was tested, for veriﬁcation purposes, on an internationally
distinct cohort of Scottish stage II CRC patients. Univariate
Cox regression was applied to test the prognostic sig-
niﬁcance of TB, PDC, CLR, and DR (Table 2) as well as
the data from the clinicopathologic report (Supplementary
Table 1, Supplemental Digital Content 1, http://links.lww.
com/PAS/A803). The results showed that TB (HR= 1.391;
95% CI, 1.038-1.863; P=0.027), DR (HR= 1.778; 95% CI,
1.230-2.571; P= 0.002), pT stage (HR= 4.001; 95% CI,
2.384-6.715; P< 0.001), and differentiation (HR= 1.481;
95% CI, 1.235-1.775; P< 0.001) were statistically signiﬁcant,
although PDC did trend to signiﬁcance. As with the
methodology applied to the Japanese cohort, CLR was not
reported as signiﬁcant when assessing DSS. KM analysis
was calculated to plot the patient stratiﬁcation and DSS
rates for TB, PDC, CLR, and DR. Higher grades of TB
or PDC and the absence of CLR was associated with
shorted DSS. The reporting of DR was the only feature to
signiﬁcantly stratify the Scottish patients (P= 0.006), where
immature stroma was shown to be associated with the
shortest DSS. CLR was again unable to signiﬁcantly stratify
the patients according to the DSS (Fig. 2). Multivariate
forward stepwise Cox regression analysis with the candidate
features of TB, PDC, CLR, and DR as input to the model,
showed that as with the Japanese cohort, DR was the only
independent predictor of shorter DSS (HR= 1.779; 95% CI,
1.230-2.572; P= 0.002) (Table 2).
DISCUSSION
The observations from this study showed that DR
was the strongest prognostic indicator of DSS in stage II
CRC when compared with TB, PDC, and CLR. DR was
the only feature that added value to a multivariate Cox
regression model in both interinstitutional cohorts and
when applying the multi-slide or the single-slide analysis.
In contrast, the current clinical gold standard for CRC
patient stratiﬁcation, pT stage, was only signiﬁcantly
correlated with DSS in the Scottish cohort. This ﬁnding,
therefore, suggests that although pT stage is an established
predictor of survival in stage II CRC, DR evaluation
TABLE 2. Univariate and Multivariate Cox Regression Analysis For Features Assessed on a Single Tissue Slide of the Japanese and
Scottish Cohorts
Univariate Multivariate
Features Frequency (%) HR (95% CI) P HR (95% CI) P
Japanese cohort
DR on 1 slide 2.982 (1.702-5.223) < 0.001 2.982 (1.702-5.223) < 0.001
Mature 107 (37.8)
Intermediate 125 (44.2)
Immature 51 (18.0)
PDC on 1 slide 1.706 (1.061-2.745) 0.028 NS
G1 124 (43.8)
G2 88 (31.1)
G3 71 (25.1)
TB on 1 slide 1.773 (1.111-2.829) 0.016 NS
G1 124 (43.8)
G2 77 (27.2)
G3 82 (29.0)
CLR on 1 slide 0.815 (0.342-1.940) 0.643 NS
Present 91 (32.2)
Absent 192 (67.8)
Scottish cohort
DR on 1 slide
Mature 56 (34.4) 1.778 (1.230-2.571) 0.002 1.779 (1.230-2.571) 0.002
Intermediate 79 (48.5)
Immature 28 (17.2)
PDC on 1 slide 1.349 (0.997-1.824) 0.052 NS
G1 52 (31.9)
G2 39 (23.9)
G3 72 (44.2)
TB on 1 slide 1.391 (1.038-1.863) 0.027 NS
G1 59 (36.2)
G2 28 (17.2)
G3 76 (46.6)
CLR on 1 slide 0.629 (0.351-1.129) 0.121 NS
Present 55 (66.3)
Absent 108 (33.7)
Signiﬁcant features (P≤ 0.05) are shown in bold.
NS indicates not signiﬁcant.
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might improve this staging system’s accuracy in
predicting DSS.
This study not only examined and compared the
prognostic signiﬁcance of known histopathologic markers in
CRC through their recommended assessment method-
ologies but also through the assessment across only 1 tissue
slide containing the deepest advancing edge of the tumor.
This single-slide method brings advantages such as con-
serving the time and effort required for the assessment of
these features while allowing their accurate evaluation with
respect to patient prognosis. Furthermore, this novel
methodology was veriﬁed across 2 distinct and international
stage II CRC cohorts. The agreement between the multi-
slide and single-slide methods of analysis was excellent for
TB, PDC, and DR and good for CLR; suggesting that the
assessment of only 1 tissue slide, containing the deepest in-
vasion of the tumor, is potentially sufﬁcient to stratify pa-
tients into prognostic categories, speciﬁcally for those
features that were signiﬁcantly associated with DSS. The
interobserver agreement for TB, PDC, and DR were all
excellent; however, the reporting of DR had the highest κ
coefﬁcient. This demonstrates that the novel single-slide
method for assessing TB, PDC, and DR reported here, is
reproducible and could be a viable and faster method for the
evaluation of these features in the future.
Both TB and PDC represent the aggressive invasion of
the tumor through the form of dedifferentiation and both
have previously been linked to adverse clinical outcome in
patients with CRC.10,32–34 Our results showed that TB was
signiﬁcantly associated with DSS regardless of their assess-
ment methodology, whereas PDC was only signiﬁcant when
assessed using the single-slide method, even though it did
trend to signiﬁcance using the recommended multi-slide as-
sessment methodology. In regard to TB, this ﬁnding concurs
well with previous results reported in the literature, whereas
regarding PDC, these results differ from those shown in
previous studies.9–11 However, our results from both meth-
odologies and cohorts revealed a strong correlation between
TB and PDC grade. This agrees with the work previously
published by Konishi et al35 while supports the idea of a
possible combined PDC and TB grade as a dedifferentiation
marker in stage II CRC, recently shown by Lee and Chan.36
In an attempt to standardize CLR reporting, we have
previously proposed a semiquantitative methodology for the
CLR assessment based on the presence or absence of lym-
phoid aggregates of size ≥1mm.17 However, in this study
using the single-slide method, CLR still had a moderate in-
terobserver concordance and held no signiﬁcant prognostic
value. This is in good agreement with a recent study,35 where
CLR was shown to have the poorest prognostic accuracy of
relapse-free survival in CRC among other factors of the tu-
mor invasive front, including the ones assessed in this study
and a moderate interobserver agreement. Although assess-
ment of CLR is readily available using routine H&E
reporting, the IMMUNOSCORE, while reliant on im-
munohistochemistry and speciﬁc commercial image analysis
software, has been demonstrated to be reproducible and
signiﬁcant in stage II CRC.16,37 The IMMUNOSCORE
measures speciﬁc densities of individual lymphocytes within
the tumor microenvironment and so may be a more accurate
representation of lymphocytic inﬁltration. This, therefore,
indicates that methodologies like IMMUNOSCORE, even
though more resource intensive, show better potential for
clinical translation of the assessment of the host lymphocytic
reaction.
Desmoplasia, deﬁned by the presence of ﬁbrosis at
the tumor’s invasive front, has been shown to be asso-
ciated with cancer aggressiveness in a number of tumor
types.19,25,38–42 Speciﬁcally, in CRC, DR has been pre-
viously shown to have a signiﬁcant association with T
stage, lymphatic and venous invasion.19 Previous research
by our team has suggested a histologic classiﬁcation of the
DR into 3 prognostic categories; mature, intermediate, or
immature, based on the keloid-like collagen presence and
myxoid stroma at the extramural desmoplastic front.21,25
These studies have shown the survival outcome to be most
favorable in patients with mature stroma, followed by the
ones with intermediate stroma and poorest in patients with
immature stroma. Similar to our previous studies, we
found DR to have a high prognostic signiﬁcance using the
same categorization system. Interestingly, DR was also
signiﬁcant when assessed through our novel method and
after international veriﬁcation, strongly supporting the
promising role of DR assessment in the stratiﬁcation of
stage II patients into prognostic subgroups based on DSS.
This ﬁts well with the study by Konishi et al,35 where
although PDC was shown to be the most signiﬁcant
prognostic marker for colon cancer recurrence, DR was
reported to be a signiﬁcant prognostic factor in their large
single-institute study. In our study, DR was also shown to
be signiﬁcantly associated with the degree of TB or PDC
regardless of the methodology of assessment or cohort.
These results conﬁrm our previous ﬁndings where a higher
degree of TB was observed more frequently in immature
stroma20,21 as well as the recent work by Konishi et al,35
where the degree of PDC was signiﬁcantly correlated with
DR. Further, it strongly highlights the pivotal role the
stroma has on tumor aggressiveness and its potential to
metastasize via tumor de-differentiation.
A key strength of the present study was the evaluation
and veriﬁcation of the novel methodology on 2 international
cohorts which consisted of tumor tissues sectioned differently
(longitudinal vs. cross-section). Furthermore, as pathology
moves closer to the full adoption of digital imaging, the sin-
gle-slide analysis was performed using digitized whole slide
images of the glass H&E in both the Japanese and Scottish
cohorts, thus allowing the methodology to be future proofed.
The glass reporting of the multi-slide method showed ex-
cellent agreement with the single-slide digital analysis for the
reporting of DR. Furthermore, digital pathology allowed for
rapid collaboration between multidisciplinary and interna-
tional colleagues, as geographic barriers could be broken
down. Finally, to make the analysis as democratic as possi-
ble, as well as scanner-agnostic, the digitization of the slides
was performed using 2 separate scanning platforms and slide
viewing software, one for each of the international cohorts.
Despite the presence of these differences, the results reporting
DR as the most signiﬁcant prognostic feature for DSS were
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consistent across methods, international cohorts and in-
dependent of scanner type.
A limitation of this study is the absence of data on
microsatellite status for both cohorts, hence their in-
corporation into the statistical analysis was not possible.
In addition, the cases presented in this study were of the
most common histologic types (adenocarcinoma, muci-
nous, or mixed), therefore it would be interesting to study
the prognostic signiﬁcance of DR in more rare and ag-
gressive subtypes of stage II CRC.
We present the ﬁrst study to examine and compare
TB, PDC, CLR, and DRwith relation to stage II CRCDSS
and their reporting from a single tissue slide, rather than the
evaluation of multiple slides. Furthermore, we are the ﬁrst
to directly verify these ﬁndings in an interinstitutional and
international study. Through both the recommended
methodologies and the newly proposed efﬁcient method, we
have shown that DR was the most signiﬁcant prognostic
feature when compared with TB, PDC, and CLR. The
present ﬁndings not only suggest that DR categorization is a
promising prognostic factor for stage II CRC but also that
the ﬁbrotic stroma at the invasive front of the tumor may
play a fundamental role in determining the CRC biological
behavior. However, further studies concerning the molec-
ular background of DR would enable the better under-
standing of the controlling inﬂuence the desmoplastic
ﬁbrotic stroma has on the tumor itself.
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